KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Finished Goods (2016 - 2026)

Edwards Lifesciences has reported Finished Goods over the past 12 years, most recently at $676.7 million for Q4 2025.

  • For Q4 2025, Finished Goods rose 11.04% year-over-year to $676.7 million; the TTM value through Dec 2025 reached $676.7 million, up 11.04%, while the annual FY2025 figure was $676.7 million, 11.04% up from the prior year.
  • Finished Goods for Q4 2025 was $676.7 million at Edwards Lifesciences, up from $642.2 million in the prior quarter.
  • Over five years, Finished Goods peaked at $676.7 million in Q4 2025 and troughed at $511.4 million in Q4 2023.
  • A 3-year average of $610.9 million and a median of $611.0 million in 2024 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: rose 19.16% in 2024 and later fell 11.1% in 2025.
  • Year by year, Finished Goods stood at $511.4 million in 2023, then rose by 19.16% to $609.4 million in 2024, then rose by 11.04% to $676.7 million in 2025.
  • Business Quant data shows Finished Goods for EW at $676.7 million in Q4 2025, $642.2 million in Q3 2025, and $630.5 million in Q2 2025.